Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group

被引:0
作者
K Behringer
H Müller
H Görgen
H-H Flechtner
C Brillant
T V Halbsguth
I Thielen
D A Eichenauer
T Schober
H Nisters-Backes
M Fuchs
A Engert
P Borchmann
机构
[1] German Hodgkin Study Group (GHSG),First Department of Internal Medicine
[2] University of Cologne,Department of Psychiatry for Children and Adolescents
[3] University of Magdeburg,undefined
来源
British Journal of Cancer | 2013年 / 108卷
关键词
Health-related quality of life (HRQoL); sexual function; Hodgkin Lymphoma; BEACOPP; fatigue; ABVD;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:49 / 57
页数:8
相关论文
共 352 条
[1]  
Aaronson NK(1993)The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 365-376
[2]  
Ahmedzai S(1998)Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution Eur J Cancer 34 p1865-p1870
[3]  
Bergman B(2011)Sexual Functioning in male survivors of lymphoma: a systematic review J Sex Med 8 1833-1840
[4]  
Bullinger M(2005)Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group J Clin Oncol 23 7555-7564
[5]  
Cull A(2009)Caring for cancer survivors: a survey of primary care physicians Cancer 115 4409-4418
[6]  
Duez NJ(2011)Eight cycles of escalated-dose BEACOPP Compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage Hodgkin's Lymphoma: final analysis of the hd12 trial of the German Hodgkin Study Group J Clin Oncol 29 4234-4242
[7]  
Filiberti A(2008)Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials Eur J Cancer 44 1793-1798
[8]  
Flechtner H(2008)Treatment-related risk factors for premature menopause following Hodgkin lymphoma Blood 111 101-108
[9]  
Fleishman SB(2010)Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 4199-4206
[10]  
de Haes JC(2009)Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study J Clin Oncol 27 4548-4554